Literature DB >> 6125288

Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.

Y Twum-Barima, D Ahmad, J T Hamilton, S G Carruthers.   

Abstract

The effects of the beta-adrenoceptor blockers atenolol, metoprolol, pindolol, and propranolol on the ventilatory response to carbon dioxide rebreathing have been determined in a double-blind randomized manner. Eight healthy, male, nonsmoking subjects received cumulative doses of each drug over a 10-hr period. The effects of each drug on heart rate and carbon dioxide sensitivity were determined at intervals of 2 hr and were related to plasma concentrations of each drug. Maximum reduction of exercise heart rate was achieved with all four beta blockers and plasma concentrations were in the usual therapeutic range for these drugs. There was considerable intersubject and within-subject variability in ventilatory responsiveness to inhaled carbon dioxide, but we were not able to discern any alteration in central sensitivity to increasing carbon dioxide concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125288     DOI: 10.1038/clpt.1982.162

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Concentration-effect relationship of oxprenolol in healthy volunteers: a retrospective analysis.

Authors:  A Racine-Poon; J Moppert
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

2.  Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade.

Authors:  H W Clague; D Ahmad; S G Carruthers
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.